IL111811A0 - Conjugates of hirudin and lipophilic compounds - Google Patents

Conjugates of hirudin and lipophilic compounds

Info

Publication number
IL111811A0
IL111811A0 IL11181194A IL11181194A IL111811A0 IL 111811 A0 IL111811 A0 IL 111811A0 IL 11181194 A IL11181194 A IL 11181194A IL 11181194 A IL11181194 A IL 11181194A IL 111811 A0 IL111811 A0 IL 111811A0
Authority
IL
Israel
Prior art keywords
hirudin
pct
conjugates
date
lipophilic compounds
Prior art date
Application number
IL11181194A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL111811A0 publication Critical patent/IL111811A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Ink Jet (AREA)
IL11181194A 1993-12-02 1994-11-29 Conjugates of hirudin and lipophilic compounds IL111811A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4341115 1993-12-02

Publications (1)

Publication Number Publication Date
IL111811A0 true IL111811A0 (en) 1995-01-24

Family

ID=6504029

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11181194A IL111811A0 (en) 1993-12-02 1994-11-29 Conjugates of hirudin and lipophilic compounds

Country Status (25)

Country Link
US (1) US5919762A (sk)
EP (1) EP0730473B1 (sk)
JP (1) JPH09505810A (sk)
CN (1) CN1142776A (sk)
AT (1) ATE204763T1 (sk)
AU (1) AU679811B2 (sk)
BR (1) BR9408195A (sk)
CA (1) CA2176967A1 (sk)
CZ (1) CZ157096A3 (sk)
DE (2) DE4437502A1 (sk)
DK (1) DK0730473T3 (sk)
ES (1) ES2163487T3 (sk)
FI (1) FI962299A0 (sk)
GR (1) GR3036938T3 (sk)
HR (1) HRP940968A2 (sk)
HU (1) HUT74390A (sk)
IL (1) IL111811A0 (sk)
NO (1) NO962261D0 (sk)
NZ (1) NZ276410A (sk)
PL (1) PL314797A1 (sk)
PT (1) PT730473E (sk)
SG (1) SG49156A1 (sk)
SK (1) SK67596A3 (sk)
WO (1) WO1995015183A1 (sk)
ZA (1) ZA949562B (sk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437604A1 (de) * 1994-10-21 1996-04-25 Basf Ag Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
US5726168A (en) * 1995-10-12 1998-03-10 Eli Lilly And Company Lipophilic benzothiophenes
DE19915862A1 (de) * 1999-04-08 2000-10-12 Max Planck Gesellschaft Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie
CA2464949A1 (en) * 2001-10-24 2003-05-01 Daniela Mavor Device and method for controlled delivery of active substance into the skin
US7438925B2 (en) * 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
BR102017005783A2 (pt) * 2017-03-21 2018-10-02 Fund Butantan processo de obtenção de esculptina e seus fragmentos, esculptina recombinante e seus usos
KR102366360B1 (ko) * 2021-06-29 2022-02-23 (주)네오팜 신규한 유사 세라마이드 화합물 및 이를 포함하는 피부 외용제 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
US4939174A (en) * 1988-02-26 1990-07-03 Shashoua Victor E Appetite suppression with dopamine-fatty acid conjugates
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
EP0462145B1 (en) * 1989-03-07 1994-04-27 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
DE4014260A1 (de) * 1989-12-01 1991-06-06 Basf Ag Hirudinpolyalkylenglykolkonjugate
JP3187044B2 (ja) * 1989-12-01 2001-07-11 ビーエーエスエフ アクチェンゲゼルシャフト ヒルジン突然変異蛋白質及びヒルジンポリアルキレングリコール複合体
WO1991009837A1 (en) * 1989-12-22 1991-07-11 Commonwealth Scientific And Industrial Research Organisation Amino acids, peptides or derivatives thereof coupled to fats
EP0537299A1 (en) * 1990-03-29 1993-04-21 Gilead Sciences, Inc. Oligonucleotide-transport agent disulfide conjugates
US5256641A (en) * 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
WO1992019233A2 (en) * 1991-04-29 1992-11-12 Control Delivery Systems, Inc. Sustained release composition and methods of use thereof
EP0541737B1 (fr) * 1991-05-02 1997-04-09 BAUDET, Pierre Les n-phenyl-cinnamamides, protecteurs contre les effets nocifs de la lumiere ultra-violette
US5359030A (en) * 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same

Also Published As

Publication number Publication date
HUT74390A (en) 1996-12-30
DE4437502A1 (de) 1995-06-08
CZ157096A3 (en) 1996-09-11
GR3036938T3 (en) 2002-01-31
HRP940968A2 (en) 1997-08-31
FI962299A (fi) 1996-05-31
BR9408195A (pt) 1997-08-26
PL314797A1 (en) 1996-09-30
SK67596A3 (en) 1996-12-04
DE59409847D1 (de) 2001-10-04
CN1142776A (zh) 1997-02-12
JPH09505810A (ja) 1997-06-10
FI962299A0 (fi) 1996-05-31
EP0730473A1 (de) 1996-09-11
DK0730473T3 (da) 2001-10-08
ES2163487T3 (es) 2002-02-01
HU9601471D0 (en) 1996-07-29
AU1067095A (en) 1995-06-19
SG49156A1 (en) 1998-05-18
AU679811B2 (en) 1997-07-10
WO1995015183A1 (de) 1995-06-08
US5919762A (en) 1999-07-06
ATE204763T1 (de) 2001-09-15
EP0730473B1 (de) 2001-08-29
PT730473E (pt) 2002-02-28
ZA949562B (en) 1996-06-03
NZ276410A (en) 1997-03-24
NO962261L (no) 1996-05-31
NO962261D0 (no) 1996-05-31
CA2176967A1 (en) 1995-06-08

Similar Documents

Publication Publication Date Title
NO308126B1 (no) Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel
BG102259A (en) Compostions with controlled paroxetine release
HK1002017A1 (en) Lyospheres comprising gonadotropin
BG101157A (en) Pesticide
MY117032A (en) A novel compound form.
MX9501850A (es) Piridilpirazoles sustituidos, procedimiento para su obtencion y composiciones pesticidas y artropodicidas que los contienen.
PL302918A1 (en) Workable cement-based compositions
PL312965A1 (en) Substituted azadioxyacyl alkenes and their application as fungicides
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
MA22946A1 (fr) Compositions de precurseurs d'agents de blanchiment.
AU8974298A (en) 1,4,7,10-tetraazabicyclo{8.2.2}tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles
CA2181665A1 (en) Synergistic stabilizer mixture
ZA949562B (en) Conjugates of hirudin and lipophilic compounds
IN225379B (sk)
AU4706293A (en) Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
CA2182148A1 (en) Process for the preparation of substituted aminocarbonyltriazolinones
MY115430A (en) Glutaramide derivatives.
IT1242475B (it) Agente colinergico, in particolare glicil-p-ammino-piridina-anilide- monoacetato, per il trattamento degli stati di demenza senile.
CA2032311A1 (en) 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors
UA19097A (uk) D-1-ФЕHІЛ-2-МЕТИЛАМІHОПРОПАHОЛА 1-5,6,7-ТРИОКСИФЛАВОH-7-0-beta-D-ГЛЮКУРОHИДАТ, ЩО МАЄ ОКИСЛЮВАЛЬHУ ДІЮ ТА РОЗШИРЮЄ СУДИHИ
UA30250A (uk) Антиоксидантний засіб
UA20123A (uk) Засіб для профілактики рецидивів виразкової хвороби дваhадцятипалої кишки